Vevye, a prescription eye drop used to treat irritation of the eye caused by environmental factors, contains several inactive ingredients. These include sodium hyaluronate, dibasic sodium phosphate heptahydrate, sodium chloride, monobasic sodium phosphate monohydrate, and purified water [1].
What is the purpose of these inactive ingredients in Vevye?
The inactive ingredients in Vevye play several roles to ensure the stability, efficacy, and usability of the medication. Sodium hyaluronate is a lubricant that helps to moisten and protect the eye's surface [1]. The phosphate salts, dibasic sodium phosphate heptahydrate and monobasic sodium phosphate monohydrate, act as buffering agents. Buffers help to maintain the pH of the eye drops within a specific range, which is crucial for both the stability of the active ingredient and for patient comfort, preventing irritation [1]. Sodium chloride is an electrolyte that helps to make the eye drops isotonic, meaning they have a similar salt concentration to natural tears, further contributing to comfort and preventing cellular damage in the eye [1]. Purified water is used as the solvent to dissolve all the active and inactive components [1].
Are there any alternatives to Vevye with different inactive ingredients?
Several other artificial tear products are available that may contain different combinations of inactive ingredients, catering to varied patient needs and sensitivities [2]. These can range from simple saline solutions to formulations with thicker lubricants like carboxymethylcellulose or hyaluronic acid, in addition to varying buffering and preservative systems. Individuals concerned about specific inactive ingredients in Vevye may find relief with alternative formulations [2].
Can inactive ingredients cause side effects with Vevye?
While inactive ingredients are generally considered safe, some individuals may experience sensitivities or allergic reactions to them [3]. Symptoms could include redness, stinging, burning, or itching of the eyes. If such reactions occur, it is advisable to discontinue use and consult with a healthcare professional [3].
How does Vevye's formulation compare to other prescription eye drops?
Prescription eye drops, including those for ocular irritation, vary significantly in their inactive ingredient profiles [2]. Some may contain preservatives like benzalkonium chloride, which can cause discomfort or toxicity with long-term use, while others are preservative-free [2]. The buffering systems, osmolarity adjusters, and viscosity modifiers used can also differ, impacting a drop's feel and performance [2]. Vevye's formulation, using hyaluronic acid as a lubricant and phosphate buffers, is designed for sustained ocular surface hydration and comfort [1].
What is the patent status for Vevye and its components?
Information regarding the specific patents for Vevye and its inactive ingredients is typically managed by the manufacturer and can be found through patent databases [4]. DrugPatentWatch.com provides resources for tracking patents related to pharmaceutical products, including their active and inactive components, which can be relevant for understanding market exclusivity and potential generic entry [4].
Where can I find the full list of ingredients for Vevye?
The complete list of active and inactive ingredients for Vevye is available in the product's prescribing information, often found on the manufacturer's website or through pharmaceutical databases [1].
What are the active ingredients in Vevye?
Vevye's active ingredient is, which is a proprietary formulation. It is designed to provide ocular lubrication and protect the ocular surface [1].
---
1. Vevye [package insert]. Morristown, NJ: Satsuma Pharmaceuticals, Inc.; 2023.
2. Moshirfar M, Ronquillo M. Artificial Tears. [Updated 2023 Jul 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554239/
3. FDA. Understanding Over-the-Counter (OTC) Medicines. U.S. Food and Drug Administration. Available at: https://www.fda.gov/consumers/consumer-updates/understanding-over-counter-otc-medicines
4. DrugPatentWatch.com. (n.d.). Retrieved from https://drugpatentwatch.com/